Janus faces of amyloid proteins in neuroinflammation

Journal of Clinical Immunology

Volumn 34, Issue SUPPL. 1, 2014, Pages

  Steinman, Lawrence ^a   Rothbard, Jonathan B ^a   Kurnellas, Michael P ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

Amyloidl; Experimental autoimmune encephalomyelitis; Hexapeptide; Multiple sclerosis; Neuroinflammation

Indexed keywords

AMYLOID PROTEIN; INTERLEUKIN 6;

ALZHEIMER DISEASE; ANIMAL; BRAIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HUMAN; IMMUNOLOGY; MOUSE; MULTIPLE SCLEROSIS; NEUROGENIC INFLAMMATION;

ALZHEIMER DISEASE; AMYLOIDOGENIC PROTEINS; ANIMALS; BRAIN; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; HUMANS; INTERLEUKIN-6; MICE; MULTIPLE SCLEROSIS; NEUROGENIC INFLAMMATION;

EID: 84905158411     PISSN: 02719142     EISSN: 15732592     Source Type: Journal    
DOI: 10.1007/s10875-014-0034-3     Document Type: Article

References (14)

1. van Noort JM, van Sechel AC, Bajramovic JJ, el Ouagmiri M, Polman CH, Lassmann H, et al. The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis. Nature. 1995;375(6534):798-801.
2. Ousman SS, Tomooka BH, Van Noort JM, Wawrousek EF, O'Conner K, Hafler DA, et al. Protective and therapeutic role for aB-crystallin in autoimmune demyelination. Nature. 2007;448:474-9. (Pubitemid 47123511)
3. Han MH, Hwang S, Roy DB, Lundgren DH, Price JV, Ousman S, et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature. 2008;451:1076-81. (Pubitemid 351317445)
4. Arac A, Brownell SE, Rothbard JB, Chen C, Ko RM, Pereira MP, et al. Systemic augmentation of {alpha}B-crystallin provides therapeutic benefit twelve hours post-stroke onset via immune modulation. Proc Natl Acad Sci U S A. 2011;108(32):13287-92.
5. Pangratz-Fuehrer S, Kaur K, Ousman SS, Steinman L, Liao YJ. Functional rescue of experimental ischemic optic neuropathy with aB-crystallin. Eye. 2011;25(6):809-17.
6. Velotta JB, Kimura N, Chang SH, Chung J, Itoh S, Rothbard J, et al. αB-crystallin improves murine cardiac function and attenuates apoptosis in human endothelial cells exposed to ischemia-reperfusion. Ann Thorac Surg. 2011;91(6):1907-13.
7. Kurnellas MP, Adams CM, Sobel RA, Steinman L, Rothbard JR. Amyloid fibrils composed of hexameric peptides attenuate neuro-inflammation. Sci Transl Med. 2013;179:179ra42.
8. Grant JL, Bou Ghosn EE, Axtell RC, Herges K, Kuipers HF, Woodling NS, et al. Unexpected therapeutic benefit from peripheral administration of amyloid-β in Th1- and Th17-versions of experimental autoimmune encephalomyelitis. Sci Transl Med. 2012;4:145ra105.
9. Rothbard JB, Kurnellas MP, Brownell S, Adams CM, Su L, Axtell RC, et al. Therapeutic effects of systemic administration of the chaperone alpha B crystallin associated with binding proinflammatory plasma proteins. J Biol Chem. 2012;287(13):9708-21.
10. Kurnellas MP, Brownell SE, Su L, Malkovskiy AV, Rajadas J, Dolganov G, et al. Chaperone activity of small heat shock proteins underlies therapeutic efficacy in experimental autoimmune encephalomyelitis. J Biol Chem. 2012;287:36423-34.
11. Tanaka N, Tanaka R, Tokuhara M, Kunugi S, Lee YF, Hamada D. Amyloid fibril formation and chaperone-like activity of peptides from alphaA-crystallin. Biochemistry. 2008;47:2961-7. (Pubitemid 351328849)
12. Gourdain P, Ballerini C, Nicot AB, Carnaud C. Exacerbation of experimental autoimmune encephalomyelitis in prion protein (PrPc)-null mice: evidence for a critical role of the central nervous system. J Neuroinflammation. 2012;9:25.
13. Ji Z, Ke ZJ, Geng JG. SAP suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice. Immunol Cell Biol. 2012;90:388-95.
14. Weinger JG, Davies P, Acker CM, Brosnan CF, Tsiperson V, Bayewitz A, et al. J Neuropathol Exp Neurol. 2012;71(5):422-33.